Literature DB >> 31757229

Approach to Patients with Eosinophilia.

Fei Li Kuang1.   

Abstract

Physicians may encounter blood or tissue eosinophilia through a routine complete blood count with differential or a tissue pathology report. In this article, the basic biology of eosinophils is reviewed and definitions of blood eosinophilia, as well as the challenges of defining tissue eosinophilia, are discussed. Conditions associated with eosinophilia are briefly discussed as well as a general approach to evaluating eosinophilia. Future challenges include determining which eosinophil-associated diseases benefit from eosinophil-targeted therapy and identifying biomarkers for disease activity and diagnosis. Published by Elsevier Inc.

Entities:  

Keywords:  Biologics; Corticosteroids; Eosinophil; Eosinophil granule proteins; Hypereosinophilia; IL-5

Mesh:

Substances:

Year:  2020        PMID: 31757229      PMCID: PMC7089574          DOI: 10.1016/j.mcna.2019.08.005

Source DB:  PubMed          Journal:  Med Clin North Am        ISSN: 0025-7125            Impact factor:   5.456


  62 in total

1.  Immune responses during human schistosomiasis mansoni. II. Occurrence of eosinophil-dependent cytotoxic antibodies in relation to intensity and duration of infection.

Authors:  A Sher; A E Butterworth; D G Colley; J A Cook; G L Freeman; P Jordan
Journal:  Am J Trop Med Hyg       Date:  1977-09       Impact factor: 2.345

Review 2.  Biologic therapies targeting eosinophils: current status and future prospects.

Authors:  Fanny Legrand; Amy D Klion
Journal:  J Allergy Clin Immunol Pract       Date:  2015 Mar-Apr

Review 3.  How I treat hypereosinophilic syndromes.

Authors:  Amy D Klion
Journal:  Blood       Date:  2015-05-11       Impact factor: 22.113

Review 4.  The DRESS syndrome: a literature review.

Authors:  Patrice Cacoub; Philippe Musette; Vincent Descamps; Olivier Meyer; Chris Speirs; Laetitia Finzi; Jean Claude Roujeau
Journal:  Am J Med       Date:  2011-05-17       Impact factor: 4.965

5.  Pulmonary eosinophilia in pulmonary tuberculosis.

Authors:  V K Vijayan; A M Reetha; M S Jawahar; K Sankaran; R Prabhakar
Journal:  Chest       Date:  1992-06       Impact factor: 9.410

6.  Long-Term Clinical Outcomes of High-Dose Mepolizumab Treatment for Hypereosinophilic Syndrome.

Authors:  Fei Li Kuang; Michael P Fay; JeanAnne Ware; Lauren Wetzler; Nicole Holland-Thomas; Thomas Brown; Hector Ortega; Jonathan Steinfeld; Paneez Khoury; Amy D Klion
Journal:  J Allergy Clin Immunol Pract       Date:  2018-05-08

7.  Eosinophilia in systemic mastocytosis: clinical and molecular correlates and prognostic significance.

Authors:  Alexandra Böhm; Manuela Födinger; Friedrich Wimazal; Oskar A Haas; Matthias Mayerhofer; Wolfgang R Sperr; Harald Esterbauer; Peter Valent
Journal:  J Allergy Clin Immunol       Date:  2007-04-23       Impact factor: 10.793

8.  Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms due to lamotrigine differs from that due to other drugs.

Authors:  Yasuya Tashiro; Hiroaki Azukizawa; Hideo Asada; Hiroyuki Niihara; Eishin Morita; Teruo Yamauchi; Yoshiko Mizukawa; Yoshio Kusakabe; Satoshi Numazawa; Miki Izumi; Hirohiko Sueki; Hideaki Watanabe
Journal:  J Dermatol       Date:  2019-01-21       Impact factor: 4.005

9.  Familial eosinophilia: a benign disorder?

Authors:  Amy D Klion; Melissa A Law; William Riemenschneider; Mary Lou McMaster; Margaret R Brown; McDonald Horne; Barbara Karp; Michael Robinson; Vandana Sachdev; Eben Tucker; Maria Turner; Thomas B Nutman
Journal:  Blood       Date:  2004-02-26       Impact factor: 22.113

Review 10.  Eosinophil cytokines, chemokines, and growth factors: emerging roles in immunity.

Authors:  Francis Davoine; Paige Lacy
Journal:  Front Immunol       Date:  2014-11-10       Impact factor: 7.561

View more
  7 in total

1.  Association Between Peripheral Eosinophilia and Clinical Characteristics of Adult-onset Still's Disease with Persistent Eruption: A Retrospective Study.

Authors:  Jia-Wei Liu; Tian Chen; Wei Liu; Ru-Xuan Chen; Yue-Tong Qian; Yan Tan; Dong-Lai Ma
Journal:  Acta Derm Venereol       Date:  2021-09-28       Impact factor: 3.875

2.  Case Report: Multimodal Imaging Guides the Management of an Eosinophilic Leukemia Patient With Eosinophilic Myocarditis and Intracardiac Thrombus.

Authors:  Jinping Si; Xinxin Zhang; Na Chen; Fangfang Sun; Ping Du; Zhiyong Li; Di Tian; Xiuli Sun; Guozhen Sun; Tao Cong; Xuemei Du; Ying Liu
Journal:  Front Cardiovasc Med       Date:  2022-06-03

3.  Clinical Features and Risk Factors of Adrenal Insufficiency in Patients With Cancer Admitted to the Hospitalist-Managed Medical Unit.

Authors:  Min Kwan Kwon; Junhwan Kim; Jonghwa Ahn; Chang-Yun Woo; Hyeonjeong Kim; Hye-Seon Oh; Mingee Lee; Seungha Hwang; Keun Hoi Park; Young Hak Lee; Jakyung Yu; Sujeung Kang; Hyo-Ju Son
Journal:  J Korean Med Sci       Date:  2022-07-18       Impact factor: 5.354

4.  Portal vein thrombosis and food protein-induced allergic proctocolitis in a premature newborn with hypereosinophilia: a case report.

Authors:  Cheong-Jun Moon; Tae Hee Kwon; Hyun-Seung Lee
Journal:  BMC Pediatr       Date:  2021-01-23       Impact factor: 2.125

5.  The percentage of peripheral eosinophils as a sensitive marker for differentiating FIGO grade in endometrial adenocarcinomas

Authors:  Serkan Akış; Uğur Kemal Öztürk; Esra Keleş; Cihat Murat Alınca; Murat Api; Canan Kabaca
Journal:  J Turk Ger Gynecol Assoc       Date:  2022-03-10

6.  Seroprevalence of toxocariasis among allergic patients in Kuwait and its association with eosinophilia.

Authors:  Mohammad Al-Awadhi; Wafaa Jamal
Journal:  Parasite Epidemiol Control       Date:  2022-07-02

7.  AST/ALT ratio as a predictor of mortality and exacerbations of PM/DM-ILD in 1 year-a retrospective cohort study with 522 cases.

Authors:  Renjiao Li; Wen-Jun Zhu; Faping Wang; Xiaoju Tang; Fengming Luo
Journal:  Arthritis Res Ther       Date:  2020-09-20       Impact factor: 5.156

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.